MK-5348-018, NCT00617123: Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183) |
|
|
| Completed | 3 | 258 | NA | Vorapaxar 2.5 mg, Placebo | Merck Sharp & Dohme LLC, The TIMI (Thrombolysis in Myocardial Infarction) Study Group, Duke Clinical Research Institute | Atherosclerosis, Ischemia, Myocardial Infarction, Cerebrovascular Accident | 10/10 | 10/10 | | |
| Completed | 3 | 26449 | NA | Vorapaxar, Placebo | Merck Sharp & Dohme LLC, The Thrombolysis in Myocardial Infarction Study (TIMI) Group | Atherosclerosis, Ischemia, Myocardial Infarction, Cerebrovascular Accident, Peripheral Arterial Disease | 12/11 | 12/11 | | |